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Thyrotropin or thyroid stimulating hormone (TSH) is aglycoprotein composed of noncovalently bound a- and b-
subunits (1). The a-subunit is common to the glycoprotein
hormone family members lutropin, follitropin, chorionic go-
nadotropin, and TSH. The b-subunit is unique and confers
specific immunogenic and hormonal functions. Classically,
TSH is synthesized and secreted by the thyrotroph cells of the
anterior pituitary, and its main function is to stimulate the
production and secretion of thyroid hormones (thyroxine [T4]
and triiodothyronine [T3]) from thyrocytes. The secretion of
TSH is in turn inhibited by circulating T4 and T3, forming a
negative feedback loop to maintain the level of thyroid hor-
mones within a narrow range. Cells outside the pituitary,
including lymphocytes, also are capable of producing TSH
(2–3), but the significance of this extra-pituitary hormone is
unclear.
Vincent et al. (4) report the first example of a TSHb splice
variant that results in the production of an alternate TSHb
protein. This splice variant was demonstrated in mouse tis-
sues, so it is important to note that the murine Tshb gene has
five exons and that the coding region is confined to exons 4–5.
The splice variant transcript begins within the distal portion
of intron 4; hence, it lacks the exon 4 codons but contains nine
novel codons derived from intron 4 followed by the exon 5
codons. The predicted protein includes the distal 71% of TSHb
and encompasses the region that interacts with the common a-
subunit. Secondary structure analysis suggests the novel first
nine amino acids may function as a hydrophobic leader se-
quence, and transfection studies in Chinese hamster ovary cells
confirmed that the TSHb variant protein is secreted. Fur-
thermore, the TSHb variant protein elicited a cAMP response
when applied to TSH receptor–expressing cells in culture.
Reverse transcription–polymerase chain reaction studies in-
dicated that the splice variant transcript is preferentially
expressed in mouse bone marrow cells and thyroid (it is pre-
sumed that bone marrow–derived cells migrating into the
thyroid account for expression in that organ). Of additional
potential interest, when mice were infected systemically with
reovirus, splice variant transcript expression increased sev-
enfold in the thyroid.
This novel TSHb variant has two important features in
addition to its potential biological activity. First, the fact that it
is generated from bone marrow cells suggests its production
and secretion may not be subject to the negative feedback
regulation of circulating T4 and T3. Second, up-regulation in
the thyroid by systemic viral infection suggests the splice
variant may influence T4 and T3 secretion in infection- or
inflammatory-related thyroid disorders.
However, a number of questions remain. Although the
authors demonstrate a cAMP response to this variant TSHb in
cultured cell lines, there was not much of a dose–response
effect and it is not known whether the variant can promote the
production and secretion of thyroid hormone from the thy-
roid gland. If it can, the TSHb variant may contribute to
thyroid hormone secretion in thyroiditis or systemic inflam-
mation in a manner independent of negative feedback from
the hypothalamic-pituitary axis. The exact nature of the bone
marrow–derived cells producing the variant TSHb needs to
be determined, as well as whether thyroid production of this
variant is indeed from such cells. The authors do not examine
whether the cellular source of variant TSHb also produces the
common a-subunit, which might allow it to function as an
intact glycoprotein dimer rather than a monomer. Although
the authors assume the variant is produced via alternative
splicing, the data are compatible with a tissue-specific pro-
moter within intron 4 driving expression of this transcript.
Since these studies were performed in mice, it would be im-
portant to determine if a similar variant transcript is produced
in humans. A comparison of the murine Tshb and human
TSHB genes reveals that the novel amino acid sequence de-
rived from intron 4 potentially could be produced from the
human gene (i.e., the putative initiator ATG is conserved) and
would be identical in seven of its nine residues. However, the
200 bp of intron 4 sequences immediately preceding the start
of the variant transcript, which might constitute a putative
tissue-specific promoter, are not conserved in the human
gene. Future studies no doubt will expand our understanding
of this interesting TSHb variant.
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